School of Public Health, The University of Queensland, Brisbane 4006, Australia.
School of Public Health and Preventative Medicine, Monash University, Melbourne 3004, Australia.
Int J Environ Res Public Health. 2021 Dec 8;18(24):12918. doi: 10.3390/ijerph182412918.
Individuals diagnosed with breast cancer have the highest rates of survival among all cancer types. Due to high survival, the costs of breast cancer to different healthcare funders are of interest. This study aimed to describe the cost to public hospital and private health funders and individuals due to hospital and emergency department (ED) admissions, as well Medicare items and pharmaceuticals over five years for Queensland women with breast cancer. We used a linked administrative dataset, CancerCostMod, limited to Queensland female breast cancer diagnoses between July 2011 and June 2013 aged 18 years or over who survived for 5 years (n = 5383). Each record was linked to Queensland Health Admitted Patient Data Collection, Emergency Department Information Systems, Medicare Benefits Schedule, and Pharmaceutical Benefits Scheme records between July 2011 and June 2018. Total costs for different healthcare funders as a result of breast cancer diagnoses were reported, with high costs and service use identified in the first six months following a breast cancer diagnosis. After the first six months post-diagnosis, the financial burdens incurred by different healthcare funders for breast cancer diagnoses in Queensland remain steady over a long period. Recommendations for reducing long term costs are discussed.
在所有癌症类型中，被诊断患有乳腺癌的个体的存活率最高。由于存活率高，不同医疗保健资金提供者对乳腺癌的成本很感兴趣。本研究旨在描述昆士兰州女性乳腺癌患者在五年内因住院和急诊部（ED）入院、医疗保险项目和药物而导致的公立医院和私人健康基金以及个人的成本。我们使用了一个链接的行政数据集 CancerCostMod，该数据集仅限于 2011 年 7 月至 2013 年 6 月期间年龄在 18 岁或以上的、生存时间为 5 年的昆士兰州女性乳腺癌诊断病例（n=5383）。每个记录都与昆士兰健康住院病人数据收集、急诊部信息系统、医疗保险福利计划和药品福利计划记录进行了链接，时间为 2011 年 7 月至 2018 年 6 月。报告了不同医疗保健资金提供者因乳腺癌诊断而产生的总成本，并确定了在乳腺癌诊断后的前六个月内存在高成本和高服务使用。在诊断后的前六个月后，昆士兰州乳腺癌诊断为不同医疗保健资金提供者带来的财务负担在很长一段时间内保持稳定。讨论了降低长期成本的建议。
